VistaGen Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VTGN and other ETFs, options, and stocks.

About VTGN

VistaGen Therapeutics, Inc. is a late clinical-stage biopharmaceutical company, which engages in developing and commercializing medication and treatment for anxiety, depression, and other central nervous system disorders. Its product portfolio includes Fasedienol (PH94B) nasal spray for social anxiety disorder, Itruvone (PH10) nasal spray for depression disorders, AV-101 oral NMDR glycine site antagonist for depression and neurological disorders, PH15 acute treatment for improvement of cognition, PH80 acute management of vasomotor symptoms due to menopause, and PH284 acute management of Wasting syndrome (Cachexia). 

CEO
Shawn K. Singh
CEOShawn K. Singh
Employees
33
Employees33
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
1998
Founded1998
Employees
33
Employees33

VTGN Key Statistics

Market cap
124.32M
Market cap124.32M
Price-Earnings ratio
-1.30
Price-Earnings ratio-1.30
Dividend yield
Dividend yield
Average volume
219.64K
Average volume219.64K
High today
$4.65
High today$4.65
Low today
$4.25
Low today$4.25
Open price
$4.43
Open price$4.43
Volume
323.94K
Volume323.94K
52 Week high
$24.71
52 Week high$24.71
52 Week low
$1.62
52 Week low$1.62
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.